{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:23:54Z","timestamp":1785291834023,"version":"3.55.0"},"reference-count":0,"publisher":"Kare Publishing","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["North Clin Istanbul"],"published-print":{"date-parts":[[2025]]},"DOI":"10.14744\/nci.2025.95881","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:01:49Z","timestamp":1762174909000},"page":"569-575","source":"Crossref","is-referenced-by-count":2,"title":["Infection and infestation-related adverse events of ocrelizumab: A disproportionality analysis using FDA adverse event reporting system"],"prefix":"10.14744","author":[{"given":"Nesrin","family":"Caglayan Duman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5966","container-title":["Northern Clinics of Istanbul"],"original-title":[],"link":[{"URL":"https:\/\/jag.journalagent.com\/nci\/pdfs\/NCI-95881-RESEARCH_ARTICLE-CAGLAYAN_DUMAN.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:01:49Z","timestamp":1762174909000},"score":1,"resource":{"primary":{"URL":"https:\/\/northclinist.com\/jvi.aspx?un=NCI-95881&volume=12&issue=5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":0,"URL":"https:\/\/doi.org\/10.14744\/nci.2025.95881","relation":{},"ISSN":["2148-4902"],"issn-type":[{"value":"2148-4902","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}